R. Scott Sykes M.D.

R. Scott Sykes, MD has a wealth of experience in medical safety and pharmacovigilance consulting. R. Scott has held various roles at esteemed pharmaceutical companies, including FibroGen, Inc. where they currently serve as the Head of Medical Safety Risk Management. Prior to that, they worked at Sykes Pharmaceutical Consulting, LLC and Curis. R. Scott also held leadership positions at G1 Therapeutics, Inc., Merz Aesthetics, Salix Pharmaceuticals, Schwarz Biosciences, Inc., and Glaxo Wellcome Inc. R. Scott'sexpertise and extensive background make him a highly qualified professional in the field.

R. Scott Sykes, MD started their education journey in 1975 at the University of North Carolina at Charlotte, where they pursued a Bachelor's Degree in Chemistry. After completing their undergraduate studies in 1979, they went on to pursue a Doctor of Medicine (M.D.) at the University of North Carolina at Chapel Hill, graduating in 1983.